NASDAQ:STML - Stemline Therapeutics Price Target & Analyst Ratings

$13.27
+0.27 (+2.08 %)
(As of 07/18/2019 05:24 AM ET)
Today's Range
$12.75
Now: $13.27
$13.34
50-Day Range
$12.67
MA: $14.28
$15.92
52-Week Range
$7.82
Now: $13.27
$17.85
Volume301,800 shs
Average Volume601,877 shs
Market Capitalization$579.70 million
P/E RatioN/A
Dividend YieldN/A
Beta1.33

Analyst Ratings

Stemline Therapeutics (NASDAQ:STML) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Stemline Therapeutics in the last 12 months. Their average twelve-month price target is $25.20, suggesting that the stock has a possible upside of 89.90%. The high price target for STML is $35.00 and the low price target for STML is $17.00. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.803.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $25.20$25.20$26.00$26.00
Price Target Upside: 89.90% upside74.52% upside96.00% upside154.65% upside

Stemline Therapeutics (NASDAQ:STML) Consensus Price Target History

Stemline Therapeutics (NASDAQ:STML) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/20/2019HC WainwrightSet Price TargetBuy$35.00HighView Rating Details
5/23/2019Roth CapitalReiterated RatingBuyHighView Rating Details
5/13/2019WedbushDowngradeOutperform ➝ Neutral$18.00HighView Rating Details
3/18/2019Piper Jaffray CompaniesSet Price TargetBuy$23.00LowView Rating Details
12/11/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$17.00MediumView Rating Details
6/15/2018CowenReiterated RatingBuyLowView Rating Details
(Data available from 7/18/2017 forward)
This page was last updated on 7/18/2019 by MarketBeat.com Staff

Featured Article: Outperform Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel